Page last updated: 2024-10-26

stallimycin and Neoplasms

stallimycin has been researched along with Neoplasms in 12 studies

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"Brostallicin is a bromoacryloyl derivative of distamycin A, which has shown very promising preclinical activity against a variety of human tumors both in vitro and in vivo."2.42Brostallicin: a new concept in minor groove DNA binder development. ( Broggini, M; Fontana, E; Fowst, C; Geroni, C; Marchini, S; Moneta, D, 2004)
"A number of anticancer drugs exert their effect by causing DNA damage and subsequent apoptosis induction."2.42Amplification of anticancer drug-induced DNA damage and apoptosis by DNA-binding compounds. ( Hiraku, Y; Kawanishi, S, 2004)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19905 (41.67)18.7374
1990's1 (8.33)18.2507
2000's5 (41.67)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arcamone, FM1
Animati, F1
Barbieri, B1
Configliacchi, E1
D'Alessio, R1
Geroni, C3
Giuliani, FC1
Lazzari, E1
Menozzi, M1
Mongelli, N1
Dutta, D1
Debnath, M1
Müller, D1
Paul, R1
Das, T1
Bessi, I1
Schwalbe, H1
Dash, J1
Rey, NA1
Neves, A1
Silva, PP1
Paula, FC1
Silveira, JN1
Botelho, FV1
Vieira, LQ1
Pich, CT1
Terenzi, H1
Pereira-Maia, EC1
DIMARCO, A1
SOLDATI, M1
FIORETTI, A1
Broggini, M2
Marchini, S2
Fontana, E1
Moneta, D1
Fowst, C1
Kawanishi, S1
Hiraku, Y1
Nelson, SM1
Ferguson, LR1
Denny, WA1
Cirò, M1
Gallinari, F1
Cozzi, P1
D'Incalci, M1
Baraldi, PG1
Romagnoli, R1
Duatti, A1
Bolzati, C1
Piffanelli, A1
Bianchi, N1
Mischiati, C1
Gambari, R1
Hori, T2
Takahashi, E2
Murata, M2
Ishihara, T1
Minamihisamatsu, M1
Kaneko, Y1
Shabtai, F1
Hart, J1
Klar, D1
Halbrecht, I1

Reviews

3 reviews available for stallimycin and Neoplasms

ArticleYear
Brostallicin: a new concept in minor groove DNA binder development.
    Anti-cancer drugs, 2004, Volume: 15, Issue:1

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Distamycins; D

2004
Amplification of anticancer drug-induced DNA damage and apoptosis by DNA-binding compounds.
    Current medicinal chemistry. Anti-cancer agents, 2004, Volume: 4, Issue:5

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antiviral Agents; Apoptosis; Bleomycin; Cations;

2004
Non-covalent ligand/DNA interactions: minor groove binding agents.
    Mutation research, 2007, Oct-01, Volume: 623, Issue:1-2

    Topics: Antineoplastic Agents; Base Sequence; Benzimidazoles; Binding Sites; Distamycins; DNA; Humans; In Vi

2007

Other Studies

9 other studies available for stallimycin and Neoplasms

ArticleYear
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.
    Journal of medicinal chemistry, 1989, Volume: 32, Issue:4

    Topics: Alkylating Agents; Animals; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Cir

1989
Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
    Nucleic acids research, 2018, 06-20, Volume: 46, Issue:11

    Topics: A549 Cells; Apoptosis; Cell Line, Tumor; Cell Proliferation; Distamycins; Down-Regulation; G-Quadrup

2018
A synthetic dinuclear copper(II) hydrolase and its potential as antitumoral: cytotoxicity, cellular uptake, and DNA cleavage.
    Journal of inorganic biochemistry, 2009, Volume: 103, Issue:10

    Topics: Animals; Antineoplastic Agents; Cell Survival; Copper; Distamycins; DNA Adducts; DNA Cleavage; Drug

2009
THE ANTIMITOTIC ACTIVITY OF ANTIBIOTIC DISTAMYCIN A.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Anti-Bacterial Agents; Antimitotic Agents; Antineoplastic Agents; Cell Division; Chick Embryo; Chrom

1964
Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.
    British journal of cancer, 1999, Volume: 80, Issue:7

    Topics: Animals; bcl-2-Associated X Protein; Blotting, Western; CDC2-CDC28 Kinases; Cell Cycle; Cyclin-Depen

1999
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents.
    Bioorganic & medicinal chemistry letters, 2000, Jun-19, Volume: 10, Issue:12

    Topics: Cysteine; Distamycins; Humans; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Radiopha

2000
Nature of distamycin A-inducible fragile sites.
    Cancer genetics and cytogenetics, 1988, Volume: 34, Issue:2

    Topics: Chromosome Banding; Chromosome Fragile Sites; Chromosome Fragility; Distamycins; Female; Genetic Mar

1988
Distamycin A-inducible fragile sites and cancer proneness.
    Cancer genetics and cytogenetics, 1988, Volume: 34, Issue:2

    Topics: Chromosome Fragile Sites; Chromosome Fragility; Disease Susceptibility; Distamycins; Female; Humans;

1988
Familial fragile site found at the cancer breakpoint (1)(q32). Inducibility by distamycin A, concomitance with fragile (16)(q22).
    Human genetics, 1986, Volume: 73, Issue:3

    Topics: Cells, Cultured; Chromosome Banding; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Hu

1986